Rockefeller Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
5,554
+1,428
| +35% | +$356K | ﹤0.01% | 1511 |
|
|
2025
Q4 | $994K | Buy |
4,126
+1,855
| +82% | +$474K | ﹤0.01% | 1561 |
|
|
2025
Q3 | $622K | Buy |
+2,271
| New | +$620K | ﹤0.01% | 1667 |
|
|
2024
Q4 | – | Sell |
-38,625
| Closed | -$9.42M | – | 1718 |
|
|
2024
Q3 | $9.42M | Sell |
38,625
-338
| -0.9% | -$75.5K | 0.03% | 562 |
|
|
2024
Q2 | $7.46M | Sell |
38,963
-22,152
| -36% | -$4.49M | 0.02% | 588 |
|
|
2024
Q1 | $12.1M | Buy |
61,115
+2,666
| +5% | +$489K | 0.04% | 446 |
|
|
2023
Q4 | $10.1M | Sell |
58,449
-7,295
| -11% | -$1.12M | 0.03% | 459 |
|
|
2023
Q3 | $9.72M | Sell |
65,744
-36,928
| -36% | -$6.68M | 0.04% | 425 |
|
|
2023
Q2 | $22.4M | Sell |
102,672
-33,417
| -25% | -$7.45M | 0.09% | 238 |
|
|
2023
Q1 | $29.8M | Buy |
136,089
+124,311
| +1,055% | +$27M | 0.13% | 181 |
|
|
2022
Q4 | $2.45M | Sell |
11,778
-133,846
| -92% | -$29.4M | 0.01% | 685 |
|
|
2022
Q3 | $31.8M | Sell |
145,624
-1,374
| -0.9% | -$313K | 0.16% | 137 |
|
|
2022
Q2 | $30.8M | Sell |
146,998
-69,617
| -32% | -$14.8M | 0.16% | 142 |
|
|
2022
Q1 | $52.5M | Sell |
216,615
-32,149
| -13% | -$7.78M | 0.25% | 93 |
|
|
2021
Q4 | $64.8M | Buy |
248,764
+974
| +0.4% | +$253K | 0.3% | 75 |
|
|
2021
Q3 | $65.3M | Sell |
247,790
-17,771
| -7% | -$4.86M | 0.34% | 66 |
|
|
2021
Q2 | $65.5M | Sell |
265,561
-6,214
| -2% | -$1.31M | 0.37% | 56 |
|
|
2021
Q1 | $52.7M | Sell |
271,775
-1,284
| -0.5% | -$257K | 0.36% | 63 |
|
|
2020
Q4 | $58M | Sell |
273,059
-6,629
| -2% | -$1.32M | 0.44% | 46 |
|
|
2020
Q3 | $47.9M | Buy |
279,688
+1,812
| +0.7% | +$335K | 0.45% | 47 |
|
|
2020
Q2 | $53.4M | Buy |
277,876
+3,916
| +1% | +$641K | 0.56% | 36 |
|
|
2020
Q1 | $40.4M | Buy |
273,960
+93,925
| +52% | +$15M | 0.53% | 36 |
|
|
2019
Q4 | $27.9M | Buy |
180,035
+475
| +0.3% | +$68.5K | 0.35% | 62 |
|
|
2019
Q3 | $24.3M | Sell |
179,560
-2,878
| -2% | -$377K | 0.33% | 73 |
|
|
2019
Q2 | $22.3M | Sell |
182,438
-3,517
| -2% | -$390K | 0.31% | 80 |
|
|
2019
Q1 | $19.3M | Buy |
185,955
+2,066
| +1% | +$213K | 0.28% | 84 |
|
|
2018
Q4 | $20.9M | Sell |
183,889
-3,760
| -2% | -$403K | 0.37% | 68 |
|
|
2018
Q3 | $21.6M | Sell |
187,649
-4,891
| -3% | -$536K | 0.33% | 74 |
|
|
2018
Q2 | $19.9M | Sell |
192,540
-5,059
| -3% | -$512K | 0.32% | 75 |
|
|
2018
Q1 | $19.5M | Buy |
+197,599
| New | +$18.7M | 0.32% | 78 |
|
Other funds holding RMD
VCM
VPM
DAM
Rockefeller Capital Management's RMD Position: Q1 2026 in Review
Rockefeller Capital Management increased its ResMed (RMD) stake by 35% in Q1 2026, buying an estimated $356K and bringing the position to 5,554 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1511.
Rockefeller Capital Management first reported a position in RMD in Q1 2018 and has held it in 30 quarters since. The position peaked at $65.5M in Q2 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Rockefeller Capital Management held 5,554 shares of ResMed worth $1.25M as of Q1 2026.
- Rockefeller Capital Management bought 1,428 ResMed shares in Q1 2026, an estimated $356K.
- ResMed made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1511 holding.
- Rockefeller Capital Management first reported a position in ResMed in Q1 2018 and has held it in 30 quarters since.
- Rockefeller Capital Management's ResMed position peaked at $65.5M in Q2 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.